Genome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanoma

British Journal of Ophthalmology

Volumn 98, Issue 6, 2014, Pages 769-774

  Cassoux, Nathalie ^a   Rodrigues, Manuel Jorge ^a   Plancher, Corine ^a   Asselain, Bernard ^a   Levy Gabriel, Christine ^a   Lumbroso Le Rouic, Livia ^a   Piperno Neumann, Sophie ^a   Dendale, Rémi ^a   Sastre, Xavier ^a   Desjardins, Laurence ^a   Couturier, Jérôme ^a  

^a INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RISK; CHROMOSOME 3; CHROMOSOME 8; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISOMY; DISOMY 3; DISOMY 8Q; FEMALE; FOLLOW UP; GENOME ANALYSIS; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MONOSOMY; MONOSOMY 3; MONOSOMY 8; MONOSOMY 8Q; ONCOLOGICAL PARAMETERS; PRIORITY JOURNAL; PROSPECTIVE STUDY; TUMOR THICKNESS; TUMOR VOLUME; UVEA MELANOMA; VERY ELDERLY;

CHOROID; DIAGNOSTIC TESTS/INVESTIGATION; GENETICS; PATHOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 8; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; MONOSOMY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; UVEAL NEOPLASMS; YOUNG ADULT;

EID: 84901639167     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2013-303867     Document Type: Article

References (31)

1. Kujalä E, Makitie T, Kivelä T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci 2003;44:4651-9. (Pubitemid 37315273)
2. Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology 2012;118:1881-5.
3. Lane AM, Egan KM, Harmon D, et al. Adjuvant interferon therapy for patients with uveal melanoma at high risk of metastasis. Ophthalmology 2009;116:2206-12.
4. Voelter V, Schalenbourg A, Pampallona S, et al. Adjuvant intra-arterial hepatic fotemustine for high-risk uveal melanoma patients. Melanoma Res 2008;18:220-4. (Pubitemid 351684668)
5. Gamel JW, McCurdy JB, McLean IW. A comparison of prognostic covariates for uveal melanoma. Invest Ophthalmol Vis Sci 1992;33:1919-22.
6. Hughes S, Damato BE, Giddings I, et al. Microarray comparative genomic hybridisation analysis of intraocular uveal melanomas identifies distinctive imbalances associated with loss of chromosome 3. Br J Cancer 2005;93:1191-6. (Pubitemid 41670705)
7. Ehlers JP, Worley L, Onken MD, et al. Integrative genomic analysis of aneuploidy in uveal melanoma. Clin Cancer Res 2008;14:115-22. (Pubitemid 351377985)
8. Trolet J, Hupe P, Huon I, et al. Genomic profiling and identification of high-risk uveal melanoma by array CGH analysis of primary tumors and liver metastases. Invest Ophthalmol Vis Sci 2009;50:2572-80.
9. Damato B, Dopierala JA, Coupland SE. Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification. Clin Cancer Res 2010;16:6083-92.
10. Onken MD, Worley LA, Tuscan MD, et al. An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma. J Mol diag 2010;12:461-8.
11. Mariani P, Piperno-Neumann S, Servois V, et al. Surgical management of liver metastases from uveal melanoma: 16 years' experience at the Institut Curie. Eur J Surg Oncol 2009;35:1192-7.
12. Leyvraz S, Keilholz U. Ocular melanoma: what's new? Curr Op Oncol 2010;24:162-9.
13. Mariani P, Servois V, Piperno-Neumann S. Therapeutic options in metastatic uveal melanoma. Dev Ophthalmol 2012;49:166-81.
14. Frenkel S, Nir I, Hendler K, et al. Long-term survival of uveal melanoma patients after surgery for liver metastases. Br J Ophthalmol 2009;93:1042-6.
15. Straatsma BR, Fine SL, Earle JD, et al. Enucleation versus plaque irradiation for choroidal melanoma. Ophthalmology 1988;95:1000-4.
16. Kivelä T, Kujalä E. Prognostication in eye cancer: the latest tumor, node, metastasis classification and beyond. Eye 2013;27:243-52.
17. Cassoux N, Cayette S, Plancher C, et al. CHOROIDAL MELANOMA: Does endoresection prevent neovascular glaucoma in patient treated with proton beam irradiation? Retina 2013;33:1441-7.
18. La Rosa P, Viara E, Hupe P, et al. VAMP: visualization and analysis of array-CGH, transcriptome and other molecular profiles. Bioinformatics 2006;22:2066-73. (Pubitemid 44390895)
19. Onken MD, Worley LA, Char DH, et al. Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma. Ophthalmology 2012;119:1596-603.
20. Harbour JW. The genetics of uveal melanoma: an emerging framework for targeted therapy. Pigment Cell Melanoma Res 2012;25:171-81.
21. Shields CL, Ganguly A, Bianciotto CG, et al. Prognosis of uveal melanoma in 500 cases using genetic testing of fine-needle aspiration biopsy specimens. Ophthalmology 2011;118:396-401.
22. Damato B, Duke C, Coupland SE, et al. Cytogenetics of uveal melanoma: a 7-year clinical experience. Ophthalmology 2007;114:1925-31.
23. Woodman SE. Metastatic uveal melanoma: biology and emerging treatments. Cancer Res 2012;18:148-52.
24. Patel M, Smyth E, Chapman PB, et al. Therapeutic implications of the emerging molecular biology of uveal melanoma. Clin cancer res 2011;(8):2087-100.
25. Hawkins BS. Collaborative ocular melanoma study randomized trial of I-125 brachytherapy. Clin trials 2011;8:661-73.
26. Dendale R, Lumbroso-Le Rouic L, Noel G, et al. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO). Int J Radiat Oncol Biol Phys 2006;65:780-7. (Pubitemid 43795817)
27. Egan KM, Ryan LM, Gragoudas ES. Survival implications of enucleation after definitive radiotherapy for choroidal melanoma: an example of regression on time-dependent covariates. Arch Ophthalmol 1998;116:366-70.
28. Damato B, Lecuona K. Conservation of eyes with choroidal melanoma by a multimodality approach to treatment: an audit of 1632 patients. Ophthalmology 2004;111:977-83. (Pubitemid 38586694)
29. Harbour JW, Onken MD, Roberson ED, et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 2010;330:1410-13.
30. Harbour JW, Roberson ED, Anbunathan H, et al. Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma. Nat Genet 2013;45:133-5.
31. Madic J, Piperno-Neumann S, Servois V, et al. Pyrophosphorolysis- activated polymerization detects circulating tumor DNA in metastatic uveal melanoma. Clin Cancer Res 2012;18:3934-41.